Bunkerhill Health vs Ultromics EchoGo

A health system that wants one contract for referral queues, oral-oncolytic prior authorization and sepsis documentation queries goes to Bunkerhill. Its homepage calls the product a long-horizon AI agent for health systems, and openFDA lists nine 510(k) decisions under the Bunkerhill names, the first dated April 25, 2023 and the latest March 6, 2026. The Trust Center states SOC 2, HIPAA and ISO 27001:2022.

For a CMIO who needs referrals, prior authorization and imaging under one agreement, Ultromics is the lesser fit. EchoGo is cleared as a diagnostic aid for HFpEF and as a screening aid for amyloidosis, both read from echo.

Ultromics belongs to a cardiology group with its own echo lab. EchoGo Heart Failure reads a single apical four-chamber view in adults over 25 with an ejection fraction of 50% or more. Bunkerhill's homepage describes its own heart failure work as follow-up for patients with an LVEF of 40% or below, a different patient group.